Research article · 24 Feb 2025
Conference abstractPublished 26 Oct 2022
Title: Three-dimensional scaffold with associated hemoxcell for supporting ipcs in diabetic nude mice subcutaneous tissue as promising preclinical trial
Urology and Nephrology Center, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The worldwide prevalence of Diabetes mellitus evoked the need for better treatment options. Tissue engineering showed a great promising modality. For this, we investigated the potential role of a three-dimensional, scalable scaffold to support IPCs survival and function in the streptozotocin- induced, diabetic nude mice subcutaneous tissue, and to address the limits of our previously tested encapsulation systems. Isolation and expansion of human mesenchymal stem cells were subsequently differentiated into IPCs according to our published trichostatin-A protocol. Forty mice, diabetes was induced in 30, and 10 served as normal controls. For each diabetic mouse, 3x106 IPCs were cultured with the cytoform-400 scaffold in xenofree media with the addition of HEMOXCell just before transplantation. HEMOXCell subcutaneous injections for 7 days were done to further improve niche conditions. Follow-up for 3 months was done. The glucose tolerance curves exhibited a normal pattern demonstrating that the cells were glucose-sensitive and insulin- responsive. Their fasting blood sugar levels were reduced in 5 of them and reached near normal values in 15 of them. The sera of all transplanted mice contained human insulin and C-peptide with a negligible amount of mouse insulin. Removal of the transplanted scaffolds was followed by a prompt return of diabetes. Intracytoplasmic insulin granules were seen by immunofluorescence in cells from the harvested scaffolds. Furthermore, all pancreatic endocrine genes were expressed. This study demonstrated that the scalable scaf-fold with modified niche conditions can provide adequate support, an important issue when stem cells are considered for the treatment of type 1 diabetes mellitus.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pathology.
Research article · 3 Feb 2025
Outbreak of Crimean Congo Haemorrhagic Fever in Northern Senegal in 2022
Review article · 16 Jan 2025
Recent Updates on Huntington Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pathology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Sherry Khater”